Sort
25,944 grants matching “neurodegeneration”
Validation of r(G4C2)exp-binding small molecules in vivo and c9FTD/ALS biomarker development
$348,955Leonard Petrucelli · Scripps Florida · P01 · FY2019 · NS
Mitigation of nuclear pore dysfunction in c9FTD/ALS pathogenesis
$348,955Jeffrey D Rothstein · Scripps Florida · P01 · FY2018 · NS
Validation of r(G4C2)exp-binding small molecules in vivo and c9FTD/ALS biomarker development
$348,955Leonard Petrucelli · Scripps Florida · P01 · FY2018 · NS
Mitigation of nuclear pore dysfunction in c9FTD/ALS pathogenesis
$348,955Jeffrey D Rothstein · Scripps Florida · P01 · FY2019 · NS
Mechanisms of Methylmercury Induced Neuronal Toxicity
$348,938Michael Aschner · Vanderbilt University · R01 · FY2010 · ES
Muscarinic Receptor Type 3 Regulation of Oligodendrocyte Progenitor Differentiation
$348,906Fraser James Sim · State University Of New York At Buffalo · R01 · FY2021 · NS
Muscarinic Receptor Type 3 Regulation of Oligodendrocyte Progenitor Differentiation
$348,906Fraser James Sim · State University Of New York At Buffalo · R01 · FY2020 · NS
Muscarinic Receptor Type 3 Regulation of Oligodendrocyte Progenitor Differentiation
$348,906Fraser James Sim · State University Of New York At Buffalo · R01 · FY2019 · NS
Muscarinic Receptor Type 3 Regulation of Oligodendrocyte Progenitor Differentiation
$348,906Fraser James Sim · State University Of New York At Buffalo · R01 · FY2018 · NS
Muscarinic Receptor Type 3 Regulation of Oligodendrocyte Progenitor Differentiation
$348,906Fraser James Sim · State University Of New York At Buffalo · R01 · FY2022 · NS
Molecular Mechanisms Governing the Homeostatic Control of Synaptic Strength
$348,898Dion Kai Dickman · University Of Southern California · R01 · FY2024 · NS
Conditional Models: Non-cell-antonomous Toxicities in HD
$348,886Xiangdong William Yang · University Of California Los Angeles · R01 · FY2006 · NS
Molecular Genetics of Tau-Associated Neurodegeneration
$348,886George R Jackson · University Of California Los Angeles · R01 · FY2006 · NS
Dynamic and Static Autoregulation Impairment in the Optic Nerve Head of Glaucoma
$348,840Lin Wang · Legacy Emanuel Hospital And Health Center · R01 · FY2013 · EY
Role of phosphoinositides in neuronal membrane traffic and neurodegeneration
$348,822Ronald K Liem · Columbia University Health Sciences · R01 · FY2015 · NS
Elucidating a molecular pathway for synaptic vesicle maintenance and degradation
$348,822Clarissa Leigh Waites · Columbia University Health Sciences · R01 · FY2016 · NS
Drug Discovery for Alzheimer's Disease
$348,780Neuronautics, Inc. · R44 · FY2004 · AG
Quantitative MR Imaging of Vascular Factors in Parkinsons Disease
$348,762Luis Hernandez-Garcia · University Of Michigan At Ann Arbor · R01 · FY2020 · NS
Anesthetic-Induced Neurotoxicity: Molecular Pathways and Genetic Risk Factors
$348,750Michael Perouansky · University Of Wisconsin-Madison · R01 · FY2020 · GM
Pathogenic Mechanisms of Environmental Toxicants in Parkinson's Disease
$348,750Lian Li · Emory University · R01 · FY2009 · ES
Alpha-synuclein aggregation disrupts motility, synaptic transmission, and calcium signaling in the myenteric plexus of the rat colon
$348,750Fredric Manfredsson · Michigan State University · R01 · FY2018 · DK
Alpha-synuclein aggregation disrupts motility, synaptic transmission, and calcium signaling in the myenteric plexus of the rat colon
$348,750Fredric Manfredsson · Michigan State University · R01 · FY2019 · DK
Enhancing the marmoset aging model through biomarker development
$348,750Ricki J Colman · University Of Wisconsin-Madison · U34 · FY2020 · AG
Alpha-synuclein aggregation disrupts motility, synaptic transmission, and calcium signaling in the myenteric plexus of the rat colon
$348,750Fredric Manfredsson · Michigan State University · R01 · FY2017 · DK
Autophagy and Neurodegeneration
$348,666Ai Yamamoto · Columbia University Health Sciences · R01 · FY2010 · NS